In Brief: FDA's Generic Drugs Advisory Committee
This article was originally published in The Tan Sheet
Executive Summary
FDA's Generic Drugs Advisory Committee: Will meet Sept. 6-7 to discuss the status of the Center for Drug Evaluation & Research's quality performance initiative in relation to formulation, dissolution and bioequivalence, as well as the advisory committee's relationship with CDER's new Office of Pharmaceutical Sciences. The meeting will be held at the Holiday Inn in Gaithersburg, Md, beginning at 8:30 a.m. on both days...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning